pre-ipo
Stage
About
Celcuity is a commercial-stage biotechnology company developing targeted therapies for multiple solid tumors, focusing on the PI3K/AKT/mTOR (PAM) pathway to improve treatment outcomes in cancers such as breast and prostate cancer.
Explore Celcuity's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.